
|Articles|January 6, 2017
Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/decrease-in-fda-drug-approvals-highlight-specialty" target="_blank">View the story "Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
5





































































































